drugset / Trial / NCT06346509
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
RandomizedSequentialTriple-blindTreatment
Summary
A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation of the administration of PORT-77 in healthy adult participants.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2025-12-27
- Completion
- 2026-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PORT-77 | Unknown | — | Oral |
Indications
No indication recorded.